In this presentation, I will discuss the controversial question: Is bilateral oophorectomy
a cause or a consequence of accelerated aging? In 2016, Levine and colleagues reported
that the premature loss of ovarian function may lead to an increase in DNA methylation,
a biological marker of accelerated aging (Levine et al., 2016). In the same year,
Rocca and colleagues reported an association between bilateral oophorectomy performed
before menopause and the rate of accumulation of multimorbidity using 18 defined chronic
conditions (Rocca et al., 2016). However, it remains difficult in a non-experimental
setting to definitively test whether accelerated aging leads to symptoms that prompt
bilateral oophorectomy, or whether bilateral oophorectomy prompts accelerated aging
(cause-effect uncertainty and confounding by indication). In a 2017 publication, we
addressed the cause-effect uncertainty with new analyses restricted to women who did
not have any of 18 chronic conditions at baseline (Rocca et al., 2017). The Rochester
Epidemiology Project records-linkage system was used to identify 420 premenopausal
women who underwent bilateral oophorectomy for a non-cancerous condition before age
46 years from 1988 to 2007 in Olmsted County, MN, and 592 age matched referent women
(±1 year) who had not undergone bilateral oophorectomy. After adjustments for several
possible confounding variables present at baseline, women who underwent oophorectomy
experienced an accelerated rate of accumulation of the 18 chronic conditions considered
together (HR = 1.24; 95% CI = 1.12–1.37; p < .001). The single-year incidence rate of new conditions was most different in the
first 6 years after oophorectomy, but the difference attenuated thereafter. Findings
did not vary by surgical indication for the oophorectomy (benign condition vs. no
ovarian condition). Current biomarker data and clinical evidence suggests that bilateral
oophorectomy is causally linked to accelerated aging.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to MaturitasAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.